CTOs on the Move

ZRT Laboratories

www.zrtlab.com

 
Not only does ZRT provide you with quality saliva and blood spot testing, we also strive to be eco-friendly and socially responsible. Environmental sustainability is also an abiding concern of ZRT founder, Dr. Zava. All laboratory processes are
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.zrtlab.com
  • 8605 SW Creekside Pl
    Beaverton, OR USA 97008
  • Phone: 503.466.2445

Executives

Name Title Contact Details

Similar Companies

Research Across America

Research Across America is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Earnhart and Associates

Earnhart and Associates Inc. is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Millennium Health

Millennium Health is a leading health solutions company that delivers accurate, timely, clinically actionable information to inform the right treatment decisions for each patient. The company shares a unified belief that everyone has the right to safe and effective treatment and aims to deliver on that idea by providing clinicians and payers with effective tools and information to reach that goal. Millennium Health offers a comprehensive suite of services including The RxAnte System, Millennium PGT and Millennium UDT, which can be used to better tailor patient care.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

MACTEC

MACTEC, Inc. is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.